.@JoshChGray et al. found that the genetic overlap between alcohol use disorder and body mass index consists of variants with mixed effect directions and implicates brain regions involved in executive functioning, reward, and food intake regulation.
https://t.co/Vv8ksVy5dN
🚨 Glucagon-like peptide-1 receptor agonists but not dipeptidyl peptidase-4 inhibitors reduce alcohol intake.
Super proud of this work supported by and done at @NIH.
@IRPatNIH@NIDAnews @NIAAAnews @DarthCTR@Lorenzo__Leggio@jclinicalinvest
https://t.co/RSls8TSBhK
@BWe1ss@RCarhartHarris Skeptical of the biomarkers bc placebo also can hit those and are distal from important patient reported outcomes.. maybe these placebo controlled trials can also benchmark/compare against typical placebo effects in non-psychedelic trials? https://t.co/C5sS6pf7QE
@guanghao_qi Sounds like a great project! I’ve been trying to integrate gwas w single cell recently and have found it challenging working with the latter data (as someone newer to this data type)
@NicoleRPrause @jamesheathers Got it - I did notice he seems to put out content on every topic under the sun. Tall order for one person to try to cover all these topics and put it out so quickly. Sounds like the guest format works best so the specific experts can share their knowledge.
Published today, our reasons for optimism that success rates in drug discovery can be improved by picking the right targets using human genetics: https://t.co/kgh9q05buE
I break the key findings down panel by panel in this thread: https://t.co/5h6q4EYYrw
I happened to be on the FDA Committee for this product. Many news agencies wanted to interview me recently; my testimony is in the public record. That said: I can't see how this product will help inform evidence based, patient-provider decisions. #stigma https://t.co/eb2MQC4YMO
Can we identify at-risk #servicemembers & better support active duty personnel with co-occurring psychiatric & pain disorders?
This pub https://t.co/bWpW1zXO5l highlights possible intervention points + potential implications for #opioid therapy.
#VisualAbstract
Can we identify at-risk #servicemembers & better support active duty personnel with co-occurring psychiatric & pain disorders?
This pub https://t.co/bWpW1zXO5l highlights possible intervention points + potential implications for #opioid therapy.
#VisualAbstract
Two open (tenure-eligible track) Associate or Assistant Professor positions in our Department of Medical and Clinical Psychology at USU. https://t.co/0mJwFqyJZ8
Research is primarily focused on genetics of alcohol use disorder and drug repurposing.
Opportunity to join a cross-institutional team (Penn, Yale, NIAAA) and build your professional network and analytic skills. Huge emphasis placed on mentorship and professional development.
Opportunity to join a cross-institutional team (Penn, Yale, NIAAA) and build your professional network and analytic skills. Huge emphasis placed on mentorship and professional development (helping you get your ideal permanent academic or industry position).
Research is primarily focused on genetics of alcohol use disorder with an eye towards drug repurposing. For a sense of the type of work see: https://t.co/seWuwOeSj0